Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2023 – Oct 2023Where it's discussed
-
X / Twitter5 posts
-
Facebook2 posts
-
YouTube1 videos
AI synopsis
What people are saying
The overall tone highlights the significance of gray matter degeneration in disease progression, with phrases like 'New in @ANA_journals' and references to ongoing initiatives indicating curiosity and recognition of the research's relevance; words like 'investigating' and mention of specific brain regions suggest active interest but limited depth in evaluating implications.
Most discussions acknowledge the article's findings, indicating general agreement on its observations that gray matter degeneration persists despite HSCT.
The posts reflect high interest, with hashtags and mentions suggesting active engagement with ongoing research in leukodystrophy and neurodegeneration.
The comments show some depth, referencing specific elements like MRI findings and enzyme activity, but lack detailed critique or alternative viewpoints.
The discussions hint at potential shifts in understanding disease progression post-transplant but don't explicitly explore broad clinical or research implications.
Abstract in brief
- Hematopoietic stem cell transplantation (HSCT) can help stabilize white matter damage in metachromatic leukodystrophy (MLD), but some patients still experience neurological decline due to gray matter pathology.
- MRI scans of worsening patients show atrophy in brain areas like the cortex, thalamus, and cerebellum, while histology reveals a lack of donor cells and low arylsulfatase A enzyme activity in gray matter structures.
- The study suggests that gray matter degeneration plays a significant role in disease progression post-transplant, indicating that HSCT might not fully address the gray matter component of MLD.]
Top posts
Most liked on X and BlueskyInvestigating #Neurodegenerative Disease After #HematopoieticStemCellTransplantation (#HSCT) in #MetachromaticLeukodystrophy New in @ANA_journals from the Global #Leukodystrophy Initiative Clinical Trials Network (@TheGLIA_CTN): https://t.co/PP0A8YdqTn
Murtadha Al-Saady: Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy https://t.co/BiBmEQEMnD
Murtadha Al-Saady: Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy https://t.co/BiBmEQEMnD
All mentions
Gray Matter Degeneration in Metachromatic Leukodystrophy Post-Transplantation
Hematopoietic stem cell transplantation can stabilize white matter damage in metachromatic leukodystrophy, but gray matter degeneration continues to cause neurological decline. MRI scans show brain atrophy, highlighting…
Investigating #Neurodegenerative Disease After #HematopoieticStemCellTransplantation (#HSCT) in #MetachromaticLeukodystrophy New in @ANA_journals from the Global #Leukodystrophy Initiative Clinical Trials Network (@TheGLIA_CTN): https://t.co/PP0A8YdqTn
Murtadha Al-Saady: Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy https://t.co/BiBmEQEMnD
Murtadha Al-Saady: Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy https://t.co/BiBmEQEMnD
Murtadha Al-Saady: Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy https://t.co/BiBmEQEMnD